Ameriprise
NUVL

Ameriprise’s Nuvalent NUVL Stock Holding History

Ameriprise’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-563,768
Closed -$57.8M – 4210
2026
Q1 		$57.8M Sell
563,768
-530
-0.1% -$54K 0.01% 797
2025
Q4 		$56.8M Buy
564,298
+37,248
+7% +$3.67M 0.01% 810
2025
Q3 		$45.6M Buy
527,050
+42,707
+9% +$3.38M 0.01% 938
2025
Q2 		$37M Buy
484,343
+204,002
+73% +$14.9M 0.01% 1021
2025
Q1 		$19.9M Buy
280,341
+42,785
+18% +$3.35M 0.01% 1321
2024
Q4 		$18.6M Buy
237,556
+171,725
+261% +$16M ﹤0.01% 1380
2024
Q3 		$6.73M Buy
+65,831
New +$5.46M ﹤0.01% 2158
2023
Q4 		– Sell
-211,923
Closed -$9.74M – 3954
2023
Q3 		$9.74M Buy
+211,923
New +$9.41M ﹤0.01% 1724

Other funds holding NUVL

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Ameriprise's NUVL Position: Q2 2026 in Review

Ameriprise sold out of Nuvalent (NUVL) in Q2 2026, closing a stake of 563,768 shares — an estimated $57.8M sold.

Ameriprise first reported a position in NUVL in Q3 2023 and held it in 8 quarters. The position peaked at $57.8M in Q1 2026. 293 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • Ameriprise reported no remaining Nuvalent position as of Q2 2026 after selling out during the quarter.
  • Ameriprise sold 563,768 Nuvalent shares in Q2 2026, an estimated $57.8M.
  • Ameriprise first reported a position in Nuvalent in Q3 2023 and held it in 8 quarters.
  • Ameriprise's Nuvalent position peaked at $57.8M in Q1 2026.
  • 293 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.